Search:



The Web

Rediff








 Latest Business news on mobile: sms BIZ to 7333

Home > Business > PTI > Report


Biocon to invest in US's Vaccinex

November 18, 2004 12:45 IST

Biotech firm Biocon will make equity investment in Vaccinex Inc. and said it has tied up with the US firm to discover and develop therapeutic antibody products for cancer, inflammation and autoimmune diseases.

As part of the collaboration, Biocon would make an equity investment in Vaccinex and both the companies would jointly work to identify at least four therapeutic antibody products, Biocon informed the Bombay Stock Exchange on Thursday.

"We are delighted to announce this partnership as Vaccinex has a strong discovery-led platform that will be beneficial to Biocon," Kiran Mazumdar-Shaw, chairman and managing director, Biocon, said.

The partnership would provide biotechnology solutions worldwide, she said.

The collaboration combines Vaccinex's capabilities to discover antibodies using its proprietary antibody discovery technology and Biocon's expertise in clinical research and biologics manufacturing.


7333: The Latest News on Your Mobile!

© Copyright 2005 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.

Share your comments




Article Tools
Email this article
Top emailed links
Print this article
Write us a letter
Discuss this article



Related Stories


Biocon launches human insulin



People Who Read This Also Read


Rs 5000 cr home loans: IDBI Bank

Multiply your money with funds!

Wipro, SAS ink pact







Copyright © 2005 rediff.com India Limited. All Rights Reserved.